TACTELVO
LIVE

Serial Number

79248061

Owner

NOVARTIS AG

Filing Date

Nov 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TACTELVO Trademark

Serial Number: 79248061 • Registration: 5816161

TACTELVO is a trademark filed by NOVARTIS AG on November 6, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,173 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 6, 2018

Registration Date

July 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

October 21, 2022

Goods & Services

[ Anti-infectives; ] anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; [ pharmaceutical preparations acting on the central nervous system; ] pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; [ pharmaceutical preparations for the prevention and treatment of cancer and tumors; ] pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma * ; except in the fields of oncology, infectious diseases and diseases of the central nervous system *

Filing History

LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jan 19, 2023 LIMN
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 6, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 6, 2022 DETH
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jun 3, 2022 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
May 29, 2022 COC.
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 6, 2020 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 18, 2020 INPR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Oct 19, 2019 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 18, 2019 COC.
NOTIFICATION PROCESSED BY IB
Oct 4, 2019 GPNX
LIMITATION OF GOODS RECEIVED FROM IB
Oct 4, 2019 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Sep 27, 2019 LIMG
FINAL DISPOSITION NOTICE SENT TO IB
Sep 17, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 17, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 29, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2019 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 23, 2019 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 27, 2019 ETOF
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTICE OF PUBLICATION
Jan 23, 2019 NPUB
APPLICATION FILING RECEIPT MAILED
Jan 8, 2019 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2019 CNSA
ASSIGNED TO EXAMINER
Jan 3, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 2, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 28, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 27, 2018 REPR